JOURNAL HOME CME HOME THIS MONTH PAST ISSUES ETOC COLLECTIONS
AUTHORS REVIEWERS EDITORIAL BOARD FEEDBACK RSS HELP
A&A International Anesthesia Research Society
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a colleague
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Web of Science (1)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kopman, A. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kopman, A. F.

Anesth Analg 2007;105:883-884
© 2007 International Anesthesia Research Society
doi: 10.1213/01.ane.0000269685.86443.a8


LETTER TO THE EDITOR

Section Editor:
Lawrence Saidman

Sugammadex–Rocuronium Dosing

Aaron F. Kopman, MD

Department of Anesthesiology (N.R. 408); Saint Vincent's Hospital Manhattan; New York, NY; akopman{at}nyc.rr.com or akopman{at}gmail.com

To the Editor:

In their recent dose-finding study, Groudine et al. (1) note that the molecular weight of sugammadex is 3.6 times that of rocuronium. They postulate that these drugs bind in a 1:1 ratio, and that as a result 1.8 mg/kg sugammadex should encapsulate all the rocuronium administered in a 0.50 mg/kg dose.

This hypothesis is perhaps overly simplistic as it does not explain all available clinical data. Following rocuronium 1.2 mg/kg, sugammadex 4.0 mg/kg does not produce prompt and complete neuromuscular block if administered 3 min (2) or 5 min later (3). Until all the data are in, I would suggest that it is premature to suggest that when sugammadex and rocuronium are administered in equimolar amounts that complete reversal of neuromuscular block will necessarily ensue.

REFERENCES

  1. Groudine SB, Soto R, Lien C, Drover D, Roberts K. A randomized, dose-finding, phase II study of the selective relaxant binding drug, sugammadex, capable of safely reversing profound rocuronium-induced neuromuscular block. Anesth Analg 2007;104:555–62[Abstract/Free Full Text]
  2. Rex C, Khuenl-Brady K, Sielenkaemper A, Kjaer CC, Puehringer FK. Reversal of high-dose rocuronium (1.2 mg/kg) with org 25969. Anesthesiology 2005;103:A1129
  3. de Boer H, Marcus M, Schouten P, Heeringa M, Driessen J. Reversal of rocuronium-induced (1.2 mg · kg–1) neuromuscular block by org 25969: a multi center dose finding and safety study. Anesthesiology 2005;103:A1117




This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a colleague
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Web of Science (1)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kopman, A. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kopman, A. F.


Lippincott, Williams & Wilkins Anesthesia & Analgesia® is published for the International Anesthesia Research Society® by Lippincott Williams & Wilkins and Stanford University Libraries' HighWire Press®. Copyright 2007 by the International Anesthesia Research Society. Online ISSN: 1526-7598   Print ISSN: 0003-2999 HighWire Press